Skip to main content
SpringerLink
Log in

Sexual Health

  • Chapter
  • First Online:
Menopause

Abstract

Sexual health can be defined as a state of physical, emotional, mental and social well-being that is related to sexuality and not merely the absence of disease, dysfunction or infirmity. The sexual health of individuals requires them to have a positive and respectful attitude towards sexuality and sexual relations and the possibility of having sexual experiences that are pleasurable, safe and free of coercion, discrimination, and violence. Therefore, sexual health is not exclusive to the prevention of sexually transmitted diseases; it also entails a broader approach that is related to the full development of a person’s welfare, health, education and love [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization. Defining sexual health: report of a technical consultation on sexual health, 28–31 January 2002. Geneva: WHO; 2006.

    Google Scholar 

  2. Sánchez-Borrego R, Molero F, Castaño R, Castelo-Branco C, Honrado M, Jurado AR, et al. Spanish consensus on sexual health in men and women over 50. Maturitas. 2014;78:138–45.

    Article  PubMed  Google Scholar 

  3. Mendoza N, Sánchez-Borrego R, Cancelo MJ, Calvo A, Checa MA, Cortés J, et al. Position of the Spanish menopause society regarding the management of perimenopause. Maturitas. 2013;74(3):283–90.

    Article  CAS  PubMed  Google Scholar 

  4. Genazzani AR, Gambacciani M, Simoncini T. Menopause and aging, quality of life and sexuality. Climacteric. 2007;10(2):88–96.

    Article  CAS  PubMed  Google Scholar 

  5. Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and Sexuality (WISHeS). Menopause. 2006;13(1):46–56.

    Article  PubMed  Google Scholar 

  6. Cabello SF. Aspectos psicosociales del manejo de la disfunción eréctil. Hábitos tóxicos y estilo de vida. La pareja en la disfunción eréctil. Psicoterapia y terapia de pareja. Arch Esp Urol. 2010;63(8):693–702.

    Google Scholar 

  7. Basson R, Brotto LA, Laan E, Redmond G, Utian WH. Assessment and management of women’s sexual dysfunctions: problematic desire and arousal. J Sex Med. 2005;2(3):291–300.

    Article  PubMed  Google Scholar 

  8. Basson R. Human sexual response. Handb Clin Neurol. 2015;130:11–8.

    Article  PubMed  Google Scholar 

  9. Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med. 2012;9(6):1497–507.

    Article  PubMed  Google Scholar 

  10. Coyne KS, Sexton CC, Thompson C, Kopp ZS, Milsom I, Kaplan SA. The impact of oab on sexual health in men and women: results from epiLUTS. J Sex Med. 2011;8(6):1603–15.

    Article  PubMed  Google Scholar 

  11. Falk SJ, Dizon DS. Sexual dysfunction in women with cancer. Fertil Steril. 2013;100(4):916–21.

    Article  PubMed  Google Scholar 

  12. Sánchez-Borrego R, Mendoza N, Beltrán E, Comino R, Allué J, Castelo-Branco C, et al. Position of the Spanish Menopause Society regarding the management of menopausal symptoms in breast cancer patients. Maturitas. 2013;75(3):294–300.

    Article  PubMed  Google Scholar 

  13. Thakar R. Is the uterus a sexual organ? Sexual function following hysterectomy. Sex Med Rev. 2015;3:264–78.

    Article  PubMed  Google Scholar 

  14. Mas M. Fisiología de la respuesta sexual femenina: actualización. Rev Int Androl. 2007;1:11–21.

    Google Scholar 

  15. Watson T. Vaginal cuff closure with abdominal hysterectomy A new approach. J Reprod Med. 1994;39:903–7.

    CAS  PubMed  Google Scholar 

  16. Flory N, Bissonnette F, Amsel RT, Binik YM. The psychosocial outcomes of total and subtotal hysterectomy: a randomized controlled trial. J Sex Med. 2006;3:483–91.

    Article  PubMed  Google Scholar 

  17. ACOG. ACOG Practice bulletin no. 89. Elective and risk-reducing salpingo-oophorectomy. Obstet Gynecol. 2008;111:231–41.

    Article  Google Scholar 

  18. Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C, et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol. 2011;121:163–8.

    Article  CAS  PubMed  Google Scholar 

  19. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med. 2006;3(2):212–22.

    Article  PubMed  Google Scholar 

  20. Bober SL, Recklitis CJ, Bakan J, Garber JE, Patenaude AF. Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention. J Sex Med. 2015;12:189–97.

    Article  PubMed  Google Scholar 

  21. Tucker PE, Bulsara MK, Salfinger SG, Jit-Sun Tan J, Green H, Cohen PA. Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy. Gynecol Oncol. 2016;140:95–100.

    Article  PubMed  Google Scholar 

  22. Brotto LA, Branco N, Dunkley C, McCullum M, McAlpine JN. Risk-reducing bilateral salpingo-oophorectomy and sexual health: a qualitative study. J Obstet Gynaecol Can. 2012;34(2):172–8.

    Article  PubMed  Google Scholar 

  23. Nastri CO, Lara LA, Ferriani RA, Rosa-E-Silva AC, Figueiredo JB, Martins WP. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2013;4(6):CD009672.

    Google Scholar 

  24. Mendoza N, Abad P, Baró F, Cancelo MJ, Llaneza P, Manubens M, et al. Spanish menopause society position statement: use of tibolone in postmenopausal women. Menopause. 2013;20(7):754–60.

    Article  PubMed  Google Scholar 

  25. Nappi RE, Kokot-Kierepa M. Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67:233–8.

    Article  PubMed  Google Scholar 

  26. Wylie K, Rees M, Hackett G, Anderson R, Bouloux PM, Cust M, Goldmeier D, Kell P, Terry T, Trinick T, Wu F. Androgens, health and sexuality in women and men. Maturitas. 2010;67(3):275–89.

    Article  CAS  PubMed  Google Scholar 

  27. Mendoza N, Suárez AM, Álamo F, Bartual E, Vergara F, Herruzo A. Lipid effects, effectiveness and acceptability of tibolone versus transdermic 17ß-estradiol for hormonal replacement therapy in women with surgical menopause. Maturitas. 2000;37(1):37–43.

    Article  CAS  PubMed  Google Scholar 

  28. Cui Y, Zong H, Yan H, Li N, Zhang Y. The efficacy and safety of ospemifene in treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy: a systematic review and meta-analysis. J Sex Med. 2014;11(2):487–97.

    Article  CAS  PubMed  Google Scholar 

  29. Wurz GT, Soe LH, Degregorio MW. Ospemifene, vulvovaginal atrophy, and breast cancer. Maturitas. 2013;74:220–5.

    Article  CAS  PubMed  Google Scholar 

  30. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.

    Book  Google Scholar 

  31. Basson R. The female sexual response: a different model. J Sex Marital Ther. 2000;26(1):51–65.

    Article  CAS  PubMed  Google Scholar 

  32. Parish SJ, Hahn SR. Hypoactive sexual desire disorder: a review of epidemiology, biosychology, diagnosis, and treatment. Sex Med Rev. 2016;4(2):103–20.

    Article  PubMed  Google Scholar 

  33. Pérez-López FR, Fernández-Alonso AM, Trabalón-Pastor M, Vara C, Chedraui P, Menopause Risk Assessment (MARIA) Research Group. Assessment of sexual function and related factors in mid-aged sexually active Spanish women with the sex-item female function index. Menopause. 2012;19(11):1224–30.

    Article  PubMed  Google Scholar 

  34. Basson R. Using a different model for female sexual response to address women’s problematic low sexual desire. J Sex Marithal Ther. 2001;27(5):395–403.

    Article  CAS  Google Scholar 

  35. Cumming GP, Currie HD, Moncur R, Lee AJ. Web-based survey on the effect of menopause on women’s libido in a computer-literature population. Menopause Int. 2009;15(1):8–12.

    PubMed  Google Scholar 

  36. Somboonporn W, Davis S, Seif MW, Bell R. Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev. 2005;4:CD004509.

    Google Scholar 

  37. Gohil K. Pharmaceutical approval update. Flibanserine (Addyi). PT. 2015;40(10):649–50.

    Google Scholar 

  38. Katz M, DeRogatis LR, Ackerman R, Hedges P, Lesko L, García M Jr, Sand M, BEGONIA Trial Investigators. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med. 2013;10(7):1807–15.

    Article  CAS  PubMed  Google Scholar 

  39. Scheffers CS, Armstrong S, Cantineau AE, Farquhar C, Jordan V. Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database Syst Rev. 2015;1:CD0011066Melles.

    Google Scholar 

  40. Salud Vaginal. Menoguías de la Asociación Española para el Estudio de la Menopausia (AEEM): marzo. 2014. ISBN: 978-84-940319-5-3.

    Google Scholar 

  41. Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH. A ramdomized, placebo- and active-controls trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar atrophy in postmenopausal women. Menopause. 2010;17(2):281–9.

    Article  PubMed  Google Scholar 

  42. Portman DJ, Bachmann GA, Simon JA, Ospemifene Study Group. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy. Menopause. 2013;20(6):623–30.

    Article  PubMed  Google Scholar 

  43. Constantine G, Graham S, Portman DJ, Rosen RC, Kinsberg SA. Female sexual function improved with ospemifene in postmenopausal women with vuvlar and vaginal atrophy: results of a randomized, placebo-controlled trial. Climateric. 2015;18:226–32.

    Article  CAS  Google Scholar 

  44. Lima SM, Bernardo BF, Yamada SS, Reis BF, da Silva GM, Galvao MA. Effects of glycine mas (I.) Merr. Soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomised, doublé-blind, placebo-controlled trial. Maturitas. 2014;78(3):205–11.

    Article  PubMed  Google Scholar 

  45. Morali G, Polatti F, Metelitsa EN, Mascarucci P, Magnani P, Márré GB. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arzneimittelforschung. 2006;56(3):230–8.

    PubMed  Google Scholar 

  46. Markowska J, Markowska A, Madry R. Evaluation of Cicatridina efficacy in healing and repairing process of uterine cervix, vagina and vulva-open no randomized clinical study. Gineckol Pol. 2008;79(7):494–8.

    Google Scholar 

  47. Kim MS, Lim HJ, Yang HJ, Lee MS, Shin BC, Ernst E. Ginseng for managing menopause symptoms: a systematic review of randomized clinical trials. J Ginseng Res. 2013;37(1):30–6.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Postigo S, Lima SM, Yamada SS, dos Reis BF, da Silva GM, Aoki T. Assessment of the effects of Tribulus terrestres on sexual function of menopausal women. Rev Bras Ginecol Obstet. 2016;38(3):140–6.

    Article  PubMed  Google Scholar 

  49. Yto TY, Trant AS, Polan ML. A doublé-blind placebo-controlled study of ArginMax, a nutritional supplement for enhancement of female sexual function. J Sex Marital Ther. 2001;27(5):541–9.

    Article  Google Scholar 

  50. Meston CM, Rellini AH, Telch MJ. Short and long-term effects of Ginkgo biloba extract on sexual dysfunction in women. Arch Sex Behav. 2008;37(4):530–47.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Jurado AR, Salud SF. Sexual en Atención Primaria (Curso de Formación on line en Internet). Madrid: Science Tools, 2012. (acceso 30 de septiembre de 2012). Disponible en: http://www.dpcap.es

  52. Rellini AH, Clifton J. Female orgasmic disorder. Adv Psychosom Med. 2011;31:35–56.

    Article  PubMed  Google Scholar 

  53. Ishak WW, Bokarius A, Jeffrey JK, Davis MC, Bakhta Y. Disorders of orgasm in women: a literature review of etiology and current treatments. J Sex Med. 2010;7(10):3254–68.

    Article  PubMed  Google Scholar 

  54. Frühauf S, Gerger H, Schmidt HM, Munder T, Barth J. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis. Arch Sex Behav. 2013;42(6):915–33.

    Article  PubMed  Google Scholar 

  55. Laan E, Rellini AH, Barnes T. International Society for Sexual Medicine. Standard operating procedures for female orgasmic disorder: consensus of the International Society for Sexual Medicine. J Sex Med. 2013;10(1):74–82.

    Article  PubMed  Google Scholar 

  56. Melles RJ, Dewitte MD, Terkuile MM, Peters MM, de Jong PJ. Attentional bias for pain and sex, and automatic appraisals of sexual penetration: differential patterns in dyspareunia vs vaginismus? J Sex Med. 2016;13(8):1255–62.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This chapter has been translated and corrected by Patricia R. Mollahan and American Journal Experts.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Granada, Maestro Montero, 21, 18004, Granada, Spain

    Nicolás Mendoza Ladrón de Guevara M.D., Ph.D.

  2. Instituto Europeo de Sexologia, Marbella, Málaga, Spain

    Ana Rosa Jurado M.D., Ph.D.

Authors
  1. Nicolás Mendoza Ladrón de Guevara M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Rosa Jurado M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolás Mendoza Ladrón de Guevara M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Obstetrics and Gynecology, University of Valencia, Valencia, Spain

    Antonio Cano

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

de Guevara, N.M.L., Jurado, A.R. (2017). Sexual Health. In: Cano, A. (eds) Menopause. Springer, Cham. https://doi.org/10.1007/978-3-319-59318-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59318-0_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59317-3

  • Online ISBN: 978-3-319-59318-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation